Abstract: The invention relates to a thrombin-free, fibrinogen-based biological adhesive for therapeutic use, which comprises factor Vila and a source of calcium ions. The invention also relates to the use of the biological adhesive as a medicament, in particular as a dressing for biological tissues, wounds or biomaterials.
Type:
Application
Filed:
December 13, 2012
Publication date:
June 13, 2013
Applicant:
LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES S.A.
Inventor:
LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES S.A.
Abstract: The invention relates to a thrombin-free, fibrinogen-based biological adhesive for therapeutic use, which comprises factor VIIa and a source of calcium ions. The invention also relates to the use of the biological adhesive as a medicament, in particular as a dressing for biological tissues, wounds or biomaterials.
Type:
Grant
Filed:
December 15, 2006
Date of Patent:
February 26, 2013
Assignee:
Laboratoire Francais du Fractionnement et des Biotechnologies S.A.
Abstract: The invention relates to the use of a factor H for producing a drug for treating Uremic Haemolytic Syndrome (UHS), to a method for purifying the factor H from a frozen fresh plasma and to a factor H concentrate obtainable by said method.
Type:
Application
Filed:
December 7, 2006
Publication date:
December 25, 2008
Applicant:
Laboratoire Francais Du Fractionnement Et Des Biotechnologies S.A.
Inventors:
Abdessadar Sami Chtourou, Claudine Mazurier, Michel Poulle, Bernadette Cauvin, Frederic Dhainault